Flagship’s Latest Company To Search Somatic Genome To Find New Drugs

 
• By Andrew McConaghie

Quotient Therapeutics is the fifth new start-up unveiled by Flagship this year, and will be co-located in the US and UK to tap into leading academic genomic expertise.

Kendall Square, Cambridge
Kendall Square in Cambridge, MA, home to Flagship Pioneering and scores of biopharma companies.

More from Start-Ups & SMEs

More from Business